Skip to main content
Top

Clinical and Translational Oncology

Issue 7/2007

Content (12 Articles)

News and Views

The threshold of biotechnology

E. García Jordá

Educational Series

Molecular biology of rhabdomyosarcoma

S. Gallego Melcón, J. Sánchez de Toledo Codina

Educational Series

Prostate cancer and Hedgehog signalling pathway

L. M. Antón Aparicio, R. García Campelo, J. Cassinello Espinosa, M. Valladares Ayerbes, M. Reboredo López, S. Díaz Prado, G. Aparicio Gallego

Review

Management of gastric adenocarcinoma

P. Khosravi Shahi, V. M. Díaz Muñoz de la Espada, P. García Alfonso, S. Encina García, Y. Izarzugaza Perón, J. L. Arranz Cozar, B. Hernández Marín, G. Pérez Manga

Special Article

Update in the management of ovarian and cervical carcinoma

A. Poveda, R. Salazar, J. M. del Campo, C. Mendiola, J. Cassinello, B. Ojeda, J. A. Arranz, A. Oaknin, J. García-Foncillas, M. J. Rubio, A. González Martín

Research Articles

Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables

J. Ponce Lorenzo, A. Segura Huerta, R. Díaz Beveridge, A. Giménez Ortiz, F. Aparisi Aparisi, T. Fleitas Kanonnikoff, P. Richart Aznar, H. de la Cueva Sapiña, J. Montalar Salcedo

Case Reports

Primary central nervous system lymphoma treated with rituximab plus temozolomide in a second line schedule

M. Santisteban, Y. Nieto, S. De la Cruz, J. Aristu, J. L. Zubieta, O. Fernández Hidalgo

Case Reports

Synovial sarcoma in children. A single centre experience

L. Moreno Martín-Retortillo, M. M. Andrés Moreno, A. Cañete Nieto, V. Castel Sánchez

Case Reports

Primary duodenal follicular lymphoma successfully treated with rituximab

D. Aguiar-Bujanda, I. Quiñones-Morales, R. Camacho-Galán, I. Llorca-Martínez, J. C. Rivero-Vera, U. Bohn-Sarmiento, J. Aguiar-Morales

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine